|
GGA3 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.67027999999902E-05 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.81254999999103E-05 |
| Normal-vs-Stage2 |
2.625200E-01 |
| Normal-vs-Stage3 |
2.935600E-03 |
| Normal-vs-Stage4 |
3.196200E-04 |
| Stage1-vs-Stage2 |
1.191650E-01 |
| Stage1-vs-Stage3 |
4.164000E-01 |
| Stage1-vs-Stage4 |
6.154800E-01 |
| Stage2-vs-Stage3 |
3.280800E-01 |
| Stage2-vs-Stage4 |
8.107600E-02 |
| Stage3-vs-Stage4 |
2.497400E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.96289999998545E-06 |
| Normal-vs-AfricanAmerican |
7.105000E-03 |
| Normal-vs-Asian |
5.976200E-04 |
| Caucasian-vs-AfricanAmerican |
4.633400E-01 |
| Caucasian-vs-Asian |
1.950960E-01 |
| AfricanAmerican-vs-Asian |
8.446200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.300490E-03 |
| Normal-vs-Female |
1.80771999999108E-05 |
| Male-vs-Female |
6.037600E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.61170000004363E-06 |
| Normal-vs-Age(41-60Yrs) |
6.351300E-04 |
| Normal-vs-Age(61-80Yrs) |
1.806360E-02 |
| Normal-vs-Age(81-100Yrs) |
2.528000E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.433190E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.944100E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.592570E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.326000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.746800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.436000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
3.549000E-01 |
| Classical-VS-Follicular |
5.25135490647699E-14 |
| Classical-VS-Other |
2.393400E-01 |
| Classical-VS-Normal |
7.40829952938782E-10 |
| Tall-VS-Follicular |
2.048700E-04 |
| Tall-VS-Other |
4.830000E-01 |
| Tall-VS-Normal |
5.038000E-03 |
| Follicular-VS-Other |
1.888420E-01 |
| Follicular-VS-Normal |
6.946200E-02 |
| Other-VS-Normal |
5.848600E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
6.364800E-03 |
| Normal-vs-N1 |
5.518600E-03 |
| N0-vs-N1 |
3.579600E-01 |
|
|
